Diabetes decisions — 2025

The Board denied the veteran's claims for survivor's pension, accrued benefits, and DIC under 38 U.S.C. § 1318 due to the appellant's countable income exceeding the applicable maximum annual pension rates, no unpaid VA benefits or pending claims at the time of death, and lack of service-connected disability rated totally disabling.

The Board remands the claims for service connection for diabetes mellitus, hemorrhoids, and bilateral knee osteoarthritis with patellar instability due to a pre-decisional duty to assist error.

The Board denied service connection for diabetes mellitus and remanded the claims for obstructive sleep apnea and gastroesophageal reflux disease (GERD) for further development.

The Board denied the veteran's claims for increased ratings and service connection, as well as remanded several issues for further development.

The Board denied the veteran's claims for an earlier effective date, service connection for lung cancer, and remanded claims for service connection for diabetes mellitus, type II, hypertension, and colon cancer.

The Board granted service connection for obstructive sleep apnea as secondary to the Veteran's service-connected lumbosacral spine disability, but denied service connection and higher ratings for hypertension, diabetes mellitus, type II, GERD, cervical strain with degenerative joint disease and IVDS, right upper extremity radiculopathy, and left upper extremity radiculopathy.

The Board remands the claims for a compensable rating for healed stress fracture, left third metatarsal base with neurapraxia of left anterior tibial nerve and service connection for chronic anxiety, chronic depression, diabetes, and sleep apnea due to insufficient evidence.

The Board remands the claims for service connection for a psychiatric disorder, tinnitus, bilateral hearing loss, and diabetes mellitus to allow for further development of the evidence.

The appeal for service connection for diabetes mellitus was withdrawn and dismissed, while the claim for a kidney disability is remanded for further development.

The Board granted service connection for heart disease and diabetes mellitus, both presumed to be related to herbicide exposure during the Veteran's service in Korea. However, it denied service connection for memory problems to include dementia, left foot fungal infection disability, right foot fungal infection disability, left leg disability, and right leg disability.

The Board dismissed the appeals for service connection for PTSD, diabetic retinopathy, sleep apnea, and diabetes mellitus as they were improperly filed or not properly before the Board.

The Board granted a 30 percent rating for irritable bowel syndrome (IBS) with gastroesophageal reflux disease (GERD), effective February 1, 2023.

The Veteran withdrew the appeal for all claims, including those related to service-connected hearing loss, diabetes mellitus, and diabetic peripheral neuropathy.

The Board remands the claims for service connection for coronary artery disease and type II diabetes to address whether a toxic exposure risk activity examination is warranted under the PACT Act.

The Board granted service connection for bilateral foot, cervical spine, and bilateral hip disabilities but denied service connection for an eye disability, OSA, a sinus disability, and a nail condition. The Board also denied an increased rating for hearing loss and dismissed the TDIU claim.

The Board granted earlier effective dates for the award of service connection for diabetes, CAD, and bilateral lower extremity diabetic peripheral neuropathy.

The Board granted the appeal to reinstate service connection for type II diabetes mellitus, finding that the severance was not proper.

The Board granted earlier effective dates of May 19, 2011 for service connection for CAD, diabetes mellitus type II, and hypertension based on the Veteran's presumed exposure to herbicide agents during his service in Thailand.

The Board remands the claims for service connection for type II diabetes, hypertension, and bilateral hearing loss for readjudication with new evidence.

The Board granted service connection for diabetes mellitus, type 2 and ischemic heart disease beginning August 10, 2022, under the PACT Act. The claims for these conditions prior to that date were remanded.